However, this first step in introducing prandial insulin therapy may provide a starting point for advancing to full basal–bolus treatment for those needing further intensification given individual clinical requirement based on diabetes duration, age and risk of macrovascular disease [11,12]. The gene discussed is INS; the disease is diabetes mellitus.